Business Context and Reporting Period
Company: Universal Health Services, Inc. (UHS)
Filing Type: Form 8-K (Current Report)
Date of Report: August 20, 2026
Event: Completion of a public offering of senior secured notes.
Key Financial Metrics and Transaction Details
This filing details a capital raise rather than operational performance metrics. The following debt instruments were issued:
- 2031 Notes: $600,000,000 aggregate principal amount at 5.500% interest, maturing September 1, 2031.
- 2036 Notes: $500,000,000 aggregate principal amount at 6.000% interest, maturing September 1, 2036.
- Total Proceeds: $1,100,000,000 aggregate principal amount.
- Interest Payments: Semi-annually on March 1 and September 1, commencing March 1, 2027.
- Security Status: Senior secured obligations, guaranteed by existing and future direct and indirect subsidiaries (Subsidiary Guarantors).
- Collateral: Secured by first-priority liens on certain assets of the Issuer and Secured Guarantors, ranking equally with the senior secured credit facility and existing senior secured notes.
- Credit Ratings: Investment grade ratings from both Moody's Investors Service and Standard & Poor's as of issuance.
Material Changes and Debt Structure
The issuance represents a significant expansion of the company's long-term debt profile. The new Notes rank equally in right of payment with existing senior indebtedness, including the senior secured credit facility and existing notes due in 2026, 2029, 2030, 2032, and 2034. The filing notes that proceeds were used to repay outstanding borrowings under the Issuer's revolving credit facility, with affiliates of certain underwriters receiving a portion of these proceeds.
Guidance, Covenants, and Risks
Covenants: The Indenture limits the Issuer's ability to consolidate, merge, or sell substantially all assets; create mortgages on principal properties to secure debt; and engage in certain sale and lease-back transactions.
Optional Redemption: The Issuer may redeem the 2031 Notes prior to August 1, 2031, and the 2036 Notes prior to June 1, 2036, at 100% of principal plus accrued interest and a "make whole" premium. After these dates, redemption is at 100% of principal plus accrued interest.
Change of Control: Holders have the right to require repurchase at 101% of principal if a change of control occurs and the Notes cease to have investment grade ratings. This covenant is initially suspended due to the current investment grade ratings.
Risks: The Notes are structurally subordinated to obligations of non-guarantor subsidiaries. Collateral liens may be released if the Notes maintain investment grade ratings, no default exists, and liens on other first lien obligations are released.
Investor Verification Checklist
- Verify the specific allocation of the $1.1 billion proceeds beyond the repayment of the revolving credit facility.
- Confirm the current status of the "Existing 2026 Notes" and whether the new issuance impacts their maturity or refinancing strategy.
- Review the full text of the Indenture (Exhibit 4.3) for specific definitions of "permitted liens" and asset exclusions from collateral.
- Monitor the credit rating actions by Moody's and S&P to ensure the "Change of Control" repurchase covenant remains suspended.
- Assess the impact of the new fixed interest rates (5.500% and 6.000%) on the company's overall cost of capital compared to existing debt.